MAXIMUM CREDIT VALUE. Patheon's liability for Active Materials calculated in accordance with Section 2.2 of the Agreement in a Year will not exceed, in the aggregate, the maximum credit value set forth below: PRODUCT MAXIMUM CREDIT VALUE [***] [***] Technical Disputes which cannot be resolved by negotiation as provided in Section 12.2 of the Agreement will be resolved in the following manner:
Appears in 3 contracts
Samples: Manufacturing Services Agreement (Evoke Pharma Inc), Manufacturing Services Agreement (Evoke Pharma Inc), Manufacturing Services Agreement (Evoke Pharma Inc)
MAXIMUM CREDIT VALUE. Patheon's ’s liability for Active Materials calculated in accordance with Section 2.2 of the Master Agreement for any Product in a Year will not exceed, in the aggregate, the maximum credit value set forth below: PRODUCT MAXIMUM CREDIT VALUE [***] [***] Technical Disputes which cannot be resolved by negotiation as provided in Section 12.2 of the Agreement will be resolved in the following manner:
Appears in 2 contracts
Samples: Product Agreement (Osmotica Pharmaceuticals PLC), Product Agreement (Osmotica Pharmaceuticals LTD)
MAXIMUM CREDIT VALUE. Patheon's liability for Active Materials calculated in accordance with Section 2.2 of the Master Agreement for any Product in a Year will not exceed, in the aggregate, the maximum credit value set forth below: PRODUCT MAXIMUM CREDIT VALUE [***] [***] Technical Disputes which cannot be resolved by negotiation as provided in Section 12.2 of the Agreement will be resolved in the following manner:
Appears in 2 contracts
Samples: Product Agreement (ChemoCentryx, Inc.), Product Agreement (Recro Pharma, Inc.)
MAXIMUM CREDIT VALUE. Patheon's liability for Active Materials calculated in accordance with Section 2.2 of the Master Agreement [for any Product] in a Year will not exceed, in the aggregate, the maximum credit value set forth below: PRODUCT MAXIMUM CREDIT VALUE [***] ]% of revenues (being payments of the Price) per Year received by Patheon under this Product Agreement, [***End of Product Agreement] Technical Disputes which cannot be resolved by negotiation as provided in Section 12.2 of the Agreement will be resolved in the following manner:
Appears in 2 contracts
Samples: Master Manufacturing Services Agreement (La Jolla Pharmaceutical Co), Master Manufacturing Services Agreement (Tetraphase Pharmaceuticals Inc)
MAXIMUM CREDIT VALUE. Patheon's ’s liability for Active Materials calculated in accordance with Section 2.2 of the Master Agreement for Product in a Year will not exceed, in the aggregate, the maximum credit value set forth below: PRODUCT MAXIMUM CREDIT VALUE [***] [***] Technical Disputes which cannot be resolved by negotiation as provided in Section 12.2 of the Agreement will be resolved in the following manner:
Appears in 2 contracts
Samples: Master Manufacturing Services Agreement (Acadia Pharmaceuticals Inc), Master Manufacturing Services Agreement (Acadia Pharmaceuticals Inc)
MAXIMUM CREDIT VALUE. Patheon's ’s liability for Active Materials calculated in accordance with Section 2.2 of the Master Agreement [for any Product] in a Year will not exceed, in the aggregate, the maximum credit value set forth below: PRODUCT MAXIMUM CREDIT VALUE [***[ ]% of revenues per Year to Patheon under this Product Agreement, up to a maximum of $[ ] [***] in the aggregate per Year. Technical Disputes which cannot be resolved by negotiation as provided in Section 12.2 of the Agreement will be resolved in the following manner:
Appears in 2 contracts
Samples: Master Manufacturing Services Agreement (Horizon Pharma, Inc.), Master Manufacturing Services Agreement (Horizon Pharma, Inc.)
MAXIMUM CREDIT VALUE. Patheon's liability for Active Materials calculated in accordance with Section 2.2 of the Master Agreement [for any Product] in a Year will not exceed, in the aggregate, the maximum credit value set forth below: PRODUCT MAXIMUM CREDIT VALUE [***] [***] Technical Disputes which cannot be resolved by negotiation as provided in Section 12.2 of the Agreement will be resolved in the following manner:
Appears in 1 contract
Samples: Master Manufacturing Services Agreement (Jazz Pharmaceuticals PLC)
MAXIMUM CREDIT VALUE. Patheon's liability for Active Materials calculated in accordance with Section 2.2 of the Master Agreement [for any Product] in a Year will not exceed, in the aggregate, the maximum credit value set forth below: PRODUCT MAXIMUM CREDIT VALUE […***] [***…] Technical Disputes which cannot be resolved by negotiation as provided in Section 12.2 of the Agreement will be resolved in the following manner:
Appears in 1 contract
Samples: Master Manufacturing Services Agreement (Acadia Pharmaceuticals Inc)
MAXIMUM CREDIT VALUE. Patheon's liability for Active Materials calculated in accordance with Section 2.2 of the Master Agreement for any Product in a Year will not exceed, in the aggregate, the maximum credit value set forth below: PRODUCT MAXIMUM CREDIT VALUE [***] [***] EXHIBIT A Technical Disputes which cannot be resolved by negotiation as provided in Section 12.2 of the Agreement will be resolved in the following manner:
Appears in 1 contract
Samples: Master Manufacturing Services Agreement (Recro Pharma, Inc.)
MAXIMUM CREDIT VALUE. Patheon's liability for Active Materials calculated in accordance with Section 2.2 of the Master Agreement [for any Product] in a Year will not exceed, in the aggregate, the maximum credit value set forth below: PRODUCT MAXIMUM CREDIT VALUE […***…] [***End of Product Agreement] Technical Disputes which cannot be resolved by negotiation as provided in Section 12.2 of the Agreement will be resolved in the following manner:
Appears in 1 contract
Samples: Master Manufacturing Services Agreement (Acadia Pharmaceuticals Inc)
MAXIMUM CREDIT VALUE. Patheon's liability for Active Materials calculated in accordance with Section 2.2 of the Agreement [for any Product] in a Year will not exceed, in the aggregate, the maximum credit value set forth below: PRODUCT MAXIMUM CREDIT VALUE [***] [***] Technical Disputes which cannot be resolved by negotiation as provided in Section 12.2 of the Agreement will be resolved in the following manner:
Appears in 1 contract
MAXIMUM CREDIT VALUE. Patheon's ’s liability for Active Materials calculated in accordance with Section 2.2 of the Agreement for any Product in a Year will not exceed, in the aggregate, the maximum credit value set forth below: PRODUCT MAXIMUM CREDIT VALUE Fidaxomicin […***…] percent ([…***] …]%) of Patheon’s revenues under this Agreement, in the aggregate per Year. Technical Disputes which cannot be resolved by negotiation as provided in Section 12.2 of the Agreement will be resolved in the following manner:
Appears in 1 contract
Samples: Manufacturing Services Agreement (Optimer Pharmaceuticals Inc)
MAXIMUM CREDIT VALUE. Patheon's ’s liability for Active Materials calculated in accordance with Section 2.2 of the Agreement in a Year will not exceed, in the aggregate, for the volumes indicated, the maximum credit value set forth below, expressed as a percentage of revenues to Patheon under this Agreement: PRODUCT MAXIMUM CREDIT VALUE [***] [***] Confidential treatment requested; certain information omitted and filed separately with the SEC. Technical Disputes which cannot be resolved by negotiation as provided in Section 12.2 of the Agreement will be resolved in the following manner:
Appears in 1 contract
Samples: Manufacturing Services Agreement (Chelsea Therapeutics International, Ltd.)
MAXIMUM CREDIT VALUE. Patheon's liability for Active Materials calculated in accordance with Section 2.2 of the Master Agreement [for any Product] in a Year will not exceed, in the aggregate, the maximum credit value set forth below: PRODUCT MAXIMUM CREDIT VALUE [***] [***] Technical Disputes which cannot be resolved by negotiation as provided in Section 12.2 of the Agreement will be resolved in the following manner:
Appears in 1 contract
Samples: Master Manufacturing Services Agreement (TESARO, Inc.)
MAXIMUM CREDIT VALUE. Patheon's ’s liability for Active Materials calculated in accordance with Section 2.2 of the Master Agreement [for any Product] in a Year will not exceed, in the aggregate, the maximum credit value set forth below: PRODUCT MAXIMUM CREDIT VALUE [***] [***] of revenues per Year to Patheon under this Product Agreement. Technical Disputes which cannot be resolved by negotiation as provided in Section 12.2 of the Agreement will be resolved in the following manner:
Appears in 1 contract
Samples: Master Manufacturing Services Agreement (ChemoCentryx, Inc.)